Introduction
A hallmark of atherogenesis is focalized endothelial dysfunction, which includes altered vasoregulation, activation of inflammatory processes, and compromised barrier function caused by endothelial cell (EC) apoptosis (Hu et al., 1999; Song et al., 2008) . Manifestations of dysfunctional ECs are readily observed in certain areas of the arterial tree, where disturbed flow (d-flow), hence reduced time-averaged shear stress, develops (Traub and Berk, 1998; Won et al., 2007) . Steady laminar flow (s-flow) promotes release of factors from ECs that inhibit coagulation, leukocyte diapedesis, and smooth muscle cell proliferation while simultaneously promoting EC survival (Garin et al., 2007; Reinhart-King et al., 2008) . Conversely, d-flow alters the profile of secreted factors and EC surface molecule expression that favors the opposite effects, thereby contributing to the development of atherosclerosis (Traub and Berk, 1998) . We have previously reported the critical role of PKC activation in EC apoptosis (Garin et al., 2007 ). Importantly, s-flow interferes with PKC signaling, thereby down-regulating the proapoptotic effect of the kinase. In contrast, unique atheroprone signals elicited by d-flow remain unclear.
Acting as a sensor for DNA damage, the transcription factor p53 is a key regulator of the life or death of a cell, depending on whether or not the cell can cope with the damage and repair it. Although the most-studied function of p53 is its role as a transcription factor that increases the expression of proapoptotic genes (Murray-Zmijewski et al., 2008) , recent studies have revealed its nontranscriptional proapoptotic activities. Cytosolic A therosclerosis is readily observed in regions of blood vessels where disturbed blood flow (d-flow) is known to occur. A positive correlation between protein kinase C  (PKC) activation and d-flow has been reported, but the exact role of d-flow-mediated PKC activation in atherosclerosis remains unclear. We tested the hypothesis that PKC activation by d-flow induces endothelial cell (EC) apoptosis by regulating p53. We found that d-flow-mediated peroxynitrite (ONOO  ) increased PKC activation, which subsequently induced p53 SUMOylation, p53-Bcl-2 binding, and EC apoptosis.
Both d-flow and ONOO
 increased the association of PKC with protein inhibitor of activated STATy (PIASy) via the Siz/PIAS-RING domain (amino acids 301-410) of PIASy, and overexpression of this domain of PIASy disrupted the PKC-PIASy interaction and PKC-mediated p53 SUMOylation. En face confocal microscopy revealed increases in nonnuclear p53 expression, nitrotyrosine staining, and apoptosis in aortic EC located in d-flow areas in wild-type mice, but these effects were significantly decreased in p53 / mice. We propose a novel mechanism for p53 SUMOylation mediated by the PKC-PIASy interaction during d-flow-mediated EC apoptosis, which has potential relevance to early events of atherosclerosis.
p53 promotes transcription of several proapoptotic genes (Mihara et al., 2003; Mercer et al., 2005; Bischof et al., 2006; Garner et al., 2007) . To test whether it plays a role in the ONOO  -induced EC apoptosis, we first examined the effect of ONOO  on p53 transcriptional activity in HUVECs that were overexpressing p53 with or without coexpression of a constitutively active PKC (catalytic domain of PKC [CAT] ; Garin et al., 2007) . To our surprise, ONOO  inhibited p53 transcriptional activity in control cells and also in those overexpressing p53 (Fig. 3 A) . Consistent with these results, cells transfected with CAT also showed a decreased p53 transcriptional activity (Fig. 3 B) . These results strongly suggest that ONOO  -mediated EC apoptosis is not caused by increased p53 transcriptional activation of proapoptotic genes.
It has recently been reported that cytosolic p53 directly interacts with Bcl-2 and antagonizes its antiapoptotic stabilization of the outer mitochondrial membrane (Mihara et al., 2003; Bischof et al., 2006) . Because this interaction takes place in the cytoplasm, p53 may be exported from the nucleus when PKC is activated by ONOO  . To verify this possibility, HUVECs were stimulated with ONOO  for 4 h, and p53 localization was analyzed by immunostaining (Fig. 3 C) . Interestingly, the antip53 staining contrast between the nucleus and the cytoplasm in p53 directly interacts with the B cell lymphoma/leukemia-2 (Bcl-2) family member proteins Bcl-xL and Bcl-2 and antagonizes their antiapoptotic function by stabilizing the outer mitochondrial membrane (Mihara et al., 2003) . Interestingly, antiapoptotic effects of p53 have also been reported (Mercer et al., 2005; Garner and Raj, 2008) . It is particularly interesting that p53 inhibits apoptosis of vascular smooth muscle cells and protects against atherosclerosis formation (van Vlijmen et al., 2001; Mercer et al., 2005) . However, it remains unclear how these p53 functions, especially its apoptotic effect in ECs, are regulated by flow.
SUMOylation is a posttranslational modification consisting of covalent conjugation of ubiquitin-like proteins called SUMO (small ubiquitin-like modifier) to target proteins (Hilgarth et al., 2004) . It is a reversible modification that affects target protein functions, such as subcellular localization, protein partnering, DNA binding, and regulation of transcription factors (Hilgarth et al., 2004) . Carter et al. (2007) proposed an interesting model for p53 nuclear export and stabilization. Masking of the C-terminal nuclear export signal (NES) results in nuclear localization of unmodified p53. A low level of ubiquitination by MDM2 exposes the NES, promoting p53 to interact with protein inhibitor of activated STATy (PIASy) and further modification by SUMOylation causes p53 nuclear export (Carter et al., 2007) . These data suggest an important role of SUMOylation in p53 nuclear export. In this study, we investigate the role of PKC and PIASy on d-flow-mediated endothelial p53 nuclear export and apoptosis, which may contribute to EC dysfunction and subsequent atherosclerotic plaque formation. Furthermore, we show that the cytoplasmic expression of p53 and EC apoptosis are increased in ECs in the area of d-flow in vivo.
Results

D-flow and ONOO
 , but not s-flow,
activate PKC
We first verified the potential role of shear stress in PKC activation in cultured ECs using a cone and plate type of flow apparatuses as described previously (Reinhart-King et al., 2008) . To generate d-flow, we used cones with radial grooves that were 1-mm deep. Fig. 1 (A and B) shows tracks of fluorescent beads suspended in culture media when grooved and nongrooved cones were rotated at the same speed. Although the nongrooved cone created straight unidirectional tracks indicating s-flow, tracks made by the grooved cone were short and not oriented in the same direction, indicating nonlaminar movement of the media in the dish. Using these cones, we determined the effect of s-and d-flow on PKC activation in human umbilical vein ECs (HUVECs). D-flow increased PKC phosphorylation at both Thr410 and Thr560 after 10 min of stimulation (Fig. 1 C) , whereas s-flow failed to activate PKC, although ERK5 was activated by s-flow as we reported previously (not depicted; Woo et al., 2008) . PKC phosphorylation at Thr560 was sustained longer than phosphorylation at Thr410. These data obtained from our in vitro system are consistent with in vivo data, which showed increased PKC activity in d-flow area compared with s-flow area in porcine arteries (Magid and Davies, 2005) , supporting the physiological relevance of our in vitro system. D-flow-induced PKC activation and p53 SUMOylation • Heo et al.
Next, to examine whether PKC is involved in ONOO  -mediated p53-Bcl-2 association, we expressed Ad-DN-PKC in HUVECs, treated them with ONOO  , and performed a coimmunoprecipitation assay using anti-p53 followed by immunoblotting with anti-Bcl-2. Bcl-2 coimmunoprecipitated with p53 when control cells (transduced with Ad-LacZ) were treated with ONOO  for 10 min or longer, but this coimmunoprecipitation was strongly inhibited by Ad-DN-PKC expression (Fig. 3 D and ONOO  -treated cells decreased considerably, and some punctuate staining appeared in the cytoplasm (Fig. 3 C) . No fluorescent signal was detected when only the secondary antibodies were used (unpublished data). ONOO  -induced anti-p53 staining in the cytoplasm was reduced in Ad-DN-PKC-transduced cells compared with adenovirus of LacZ (Ad-LacZ)-transduced cells, suggesting that ONOO  induced p53 export from the nucleus in a PKC-dependent manner. (A and B) Generation of s-flow and d-flow using a cone and plate flow chamber. Tracks of fluorescent beads in a cone and plate flow chamber. S-flow was generated using a nongrooved cone (A), and d-flow was generated using a grooved cone (B). Note straight tracks with s-flow and short tracks with different orientations with d-flow, which are caused by beads going out of focus. Both cones were rotated at the same speed. Color tracks indicate time x (red), time x + 10 s (green), and time x + 20 s (blue). Bright dots are beads adhered to the dish. Exposure time is 0.4 s. Bars, 100 µm. (C and D) HUVECs were stimulated by s-or d-flow (C) or ONOO  (D) for the indicated times, and PKC phosphorylation was determined by Western blotting. The level of PKC phosphorylation was determined by taking the ratio of optical densities between antiphospho-PKC and anti-PKC bands (bar graphs) as described in Materials and methods. The experiments were performed in triplicate using three different batches of s-or d-flow or ONOO  -stimulated HUVECs (means ± SD; n = 3; *, P < 0.05; and **, P < 0.01 compared with control). Molecular masses are given in kilodaltons. IB, immunoblot. may be controlled by PKC. To test this, we cotransfected HeLa cells with Flag-tagged p53 (Flag-p53), HA-tagged SUMO3 (HA-SUMO), and constitutively active PKC (CAT) and determined p53 SUMOylation by Western blotting using anti-SUMO2/3. Several bands presumably representing mono-and poly-SUMOylated p53 with apparent molecular masses of 68, 74, 82, 130, 185 , and 200 kD were noted (Fig. 4 A) . These bands were also labeled by anti-Flag, indicating that they are SUMOylated Flag-p53 (Fig. 4 A, middle) . p53 SUMOylation was increased in CAT-transfected cells, suggesting the role of (Fig. S1 A) . Collectively, these results suggest a role of PKC in ONOO  -mediated p53 nuclear export and subsequent p53-Bcl-2 interaction.
PKC mediates d-flow-and ONOO
 -induced p53 SUMOylation
Because p53 nuclear export is positively regulated by SUMOylation (Bischof et al., 2006) and also because PKC regulates p53 nuclear export (present study), p53 SUMOylation Coimmunoprecipitation using nonimmune IgG yielded no SUMOylated bands (Fig. S1 A) . To see whether endogenous p53 is SUMOylated, we specifically inhibited p53 expression using siRNA and found significantly reduced SUMOylation levels in the 68-, 74-, 82-, 130-, 160-, and 185-kD bands (Fig. 4 C) . Endogenous p53 SUMOylation bands were less discrete, likely caused by the combined effects of poly-SUMOylation and ubiquitination as previously described (Carter et al., 2007) . SENP2 (sentrin-specific protease 2) is a de-SUMOylation enzyme that is important for both processing new SUMO PKC activity on p53 SUMOylation. In addition, these sumoylated bands were diminished in the cells transfected with the p53-K386R SUMOylation mutant (Kwek et al., 2001) , further supporting that these high mass bands were SUMOylated p53.
An important role of PIASy as a SUMO E3 ligase in p53 SUMOylation has been reported (Bischof et al., 2006) . To confirm that the 4-5 bands are SUMOylated p53, HUVECs with or without CAT expression were transfected with PIASy siRNA. This should inhibit p53 SUMOylation, and indeed, PIASy depletion eliminated the appearance of these bands (Fig. 4 B) . (A and B) HUVECs were transfected with the p53-Luc reporter and Renilla luciferase-encoding plasmid (pRL-thymidine kinase) used as an internal control reporter together with p53-wild type or vector alone (pcDNA3.1; A). Some cells were further transfected with or without pcDNA3.1-CAT (B). Transcriptional activity was determined by a reporter plasmid encoding 13 copies of the p53-binding sequence (p53-Luc reporter; Kern et al., 1992) . After 24 h of transfection, p53 transcriptional activity was assayed using the dual-luciferase kit (B), or the cells were further treated with 10 or 50 µM ONOO  for 8 h as indicated, and luciferase activity was assayed (A). Data are representative of triplicates using two or more different preparations of ECs. *, P < 0.05; **, P < 0.01. (C) HUVECs were transduced with Ad-DN-PKC or Ad-LacZ as a control for 24 h, treated with vehicle or 100 µM ONOO  for 4 h, and immunostained with anti-p53 followed by DAPI counter staining for nuclei. Bar, 5 µm. (D, top) HUVECs were transduced with Ad-DN-PKC or Ad-LacZ for 24 h and stimulated with 100 µM ONOO -for the indicated times. p53-Bcl-2 binding was determined by coimmunoprecipitation with anti-p53 followed by immunoblotting with anti-Bcl-2. p53, PKC, and Bcl-2 in total cell lysates were detected by Western blotting with each specific antibody. (bottom) Quantification of p53-Bcl-2 binding expressed as the relative band intensity ratio between coimmunoprecipitated versus total Bcl-2. Results were normalized as described in Fig. 1 . n = 3. *, P < 0.05 and **, P < 0.01 compared with the vehicle control, and # , P < 0.05 and ## , P < 0.01 compared with the LacZ control at each time point. Molecular masses are given in kilodaltons. Error bars indicate means ± SD. IB, immunoblot. IP, immunoprecipitation. p53 SUMOylation in HUVECs. When HUVECs were transfected with PIASy siRNA, the ONOO  and d-flow-dependent p53 SUMOylation was inhibited (Fig. 6 A and Fig. 7 A) . Using the PIASy-depleted cells, we studied the role of PIASy in the ONOO  -elicited p53-Bcl-2 association and found that the PIASy depletion inhibited this interaction (Fig. 6 B) , suggesting that PIASy, which SUMOylates p53, is involved in ONOO  -induced p53 nuclear export and subsequent p53-Bcl-2 binding in ECs. To see whether PIASy has a role in the ONOO  and d-flow-induced EC apoptosis, ECs were transfected with PIASy siRNA, challenged by ONOO  or d-flow, and assayed for apoptosis. The number of TUNEL-positive cells and expression of cleaved caspase 3 induced by ONOO  or d-flow were downregulated by PIASy siRNA (Fig. 6 C and Fig. 7, B and C) .
To establish the role of p53 SUMOylation on d-flowmediated EC apoptosis, we transduced ECs with an adenovirus containing wild-type p53 (Ad-WT-p53) or the p53 SUMOylation site mutant (p53-K386R) and examined d-flow-mediated apoptosis compared with wild-type p53 in ECs. First, we confirmed that the adenoviral p53-K386R (Ad-p53-K386R) mutant significantly decreased p53 SUMOylation (Fig. 4 A) . Next, we found that d-flow increased apoptosis in ECs transduced by Ad-WT-p53, but transduction of the Ad-p53-K386R mutant significantly inhibited it (Fig. 7, D and E) . Because nuclear export of p53 is important for p53-Bcl-2 binding, we also used an NES mutation (L348,350A; NES; O' Keefe et al., 2003) and studied d-flowmediated EC apoptosis. As shown in Fig. S2 (A and B), in contrast to wild-type p53, we found that both p53-K386R and the NES mutant stayed in the nucleus after d-flow stimulation, and the NES mutant significantly inhibited d-flow-mediated apoptosis compared with wild type (Fig. 7, D and E) , suggesting the critical role of p53 SUMOylation and nuclear export of p53 on d-flow-mediated EC apoptosis. Collectively, these results suggest the critical role of PIASy-mediated p53 SUMOylation and subsequent nuclear export of p53 in the ONOO  and d-flowinduced EC apoptosis (Fig. S2, A and B) . As PIASy played a critical role in CAT-mediated p53 SUMOylation (Fig. 4 B) , PKC might directly phosphorylate PIASy and activate its E3 SUMO ligase activity. To test this possibility, we incubated recombinant PKC with GST-tagged PIASy fragments and found that none of the fragments was phosphorylated by PKC, whereas autophosphorylation of PKC was detected (Fig. S3 ). Although it does not phosphorylate PIASy, PKC may still interact with PIASy. We cotransfected HeLa cells with HA-tagged PKC and myc-tagged PIASy and performed a coimmunoprecipitation assay in which PKC and PIASy were coimmunoprecipitated (unpublished data). To confirm this interaction between endogenous PKC and PIASy, we stimulated HUVECs with ONOO  for the indicated times and performed coimmunoprecipitation using anti-PKC. PIASy was indeed coimmunoprecipitated by anti-PKC, and ONOO  stimulation increased the PKC-PIASy interaction (Fig. 8 A) . Next, to determine the PIASy-binding regions of PKC, we generated four proteins for conjugation as well as deconjugating SUMO from SUMOylated proteins (Cheng et al., 2004; Yeh, 2009; Witty et al., 2010) . To verify the identity of the endogenous p53 SUMOylation band, we also transduced ECs with Ad-LacZ control or adenoviral SENP2 (Ad-SENP2), stimulated them with d-flow, and evaluated changes in these multiple bands (Fig. 4 C) . Transduction of Ad-SENP2 completely reduced d-flow-induced p53 SUMOylation. These results together support that the 68-, 74-, 82-, 130-, 160-, 185-, and 200-kD bands are SUMOylated p53.
When HUVECs were treated with various concentrations of ONOO  for 10 min, p53 SUMOylation increased in a dosedependent manner (Fig. S1, A and B) . We also found that d-flow significantly increased p53 SUMOylation after 2 h of stimulation (Fig. 4 D and Fig. S1 D) . Next, we investigated whether PKC played a role in p53 SUMOylation by ONOO  and d-flow. This SUMOylation was inhibited in cells expressing Ad-DN-PKC (Fig. 4 D and Fig. S1 C) , suggesting a role of PKC in p53 SUMOylation in ONOO  and d-flow-stimulated cells. In addition, Bcl-2 coimmunoprecipitated with p53 when control cells (transduced with Ad-LacZ) were treated with d-flow, but this coimmunoprecipitation was strongly inhibited by Ad-DN-PKC transduction (Fig. 4 D) , which was also observed in ONOO  -treated cells (Fig. 3 D) . To test whether PKC plays a unique role on p53 SUMOylation and binding between p53 and Bcl-2, we transfected ECs with PKC siRNA and studied its effect on d-flow-mediated p53 SUMOylation and p53-Bcl-2 binding. As shown in Fig. 4 E, we found that PKC siRNA specifically inhibited PKC expression but not other PKC isoforms, including PKC/, PKC, PKCII, and PKC (Fig. 4 E) . Under this condition, d-flow effects on p53 SUMOylation and p53-Bcl-2 binding were significantly reduced, indicating the unique and critical role of PKC on d-flow-mediated p53 SUMOylation and its subsequent events.
ONOO  production by d-flow mediates PKC activation and p53 SUMOylation
We investigated the contribution of ONOO  production on the d-flow-mediated PKC activation and p53 SUMOylation and found that an ONOO  scavenger, ebselen, a nonselective inhibitor of NO synthesis, N-nitro-l-arginine methyl ester (L-NAME), superoxide dismutase mimetic, and an ONOO  scavenger, Mn (III)tetrakis(4-benzoic acid)porphyrin chloride (Mn-TBAP), significantly inhibited d-flow-mediated PKC activation as well as p53 SUMOylation (Fig. 5, A-C) . Moreover, these compounds strongly inhibited d-flow-induced EC apoptosis (Fig. 5, D and E) , strongly suggesting a critical role of ONOO  production in the d-flow-mediated signaling and subsequent apoptosis. and PIASy together with PIASy Fr 3. Consistent with the coimmunoprecipitation results, PIASy Fr 3 significantly inhibited the PKC-PIASy interaction (Fig. 8 E) . To demonstrate the importance of the PKC-PIASy interaction for p53 SUMOylation, ECs expressing PIASy fragments were stimulated by d-flow. As shown in Fig. 8 F, only PIASy Fr 3 inhibited d-flow-mediated p53 SUMOylation, suggesting that p53 SUMOylation depends on PKC-PIASy binding.
Morphological evidence for the PKC-PIASy and p53-Bcl-2 association was provided by confocal microscopy of coimmunostained ECs with or without flow stimulation (Fig. 9 A) . Cells cultured without flow expressed PKC mainly in the cytosol and PIASy in the nucleus as reported previously (Sachdev et al., 2001; Li et al., 2004) . However, after d-flow stimulation, PKC and PIASy were colocalized in the nucleus. As for the p53 and Bcl-2 colocalization, p53 was localized in the nucleus of unstimulated cells, whereas Bcl-2 was mainly outside the nucleus PKC-truncated mutants and evaluated their association with PIASy using a mammalian two-hybrid assay (Fig. 8, B and C) . Plasmids encoding the GAL4-DNA-binding domain and PKC (full length or one of the truncated forms) were constructed using the pBIND vector. A plasmid containing VP16-PIASy was constructed using the pACT vector. As expected, wild-type PKC bound to PIASy, and ONOO  increased this association (Fig. 8 B) . More importantly, however, we found that the C-terminal kinase domain (aa 401-587) was required for the PKC-PIASy association (Fig. 8 C) . Next, to determine the PKC binding site of PIASy, we coexpressed GST-fused PKC and Flagtagged PIASy fragments in HeLa cells and performed coimmunoprecipitation using anti-Flag. We found that PIASy fragment 3 (Fr 3; aa 301-410), which contains the Siz/PIAS RING domain, interacted with PKC (Fig. 8 D) . In a separate experiment, we examined this fragment could interfere with the PKC-PIASy association. HeLa cells were cotransfected with wild-type PKC -for the indicated times and subjected to immunoprecipitation with anti-PIASy followed by Western blotting with anti-PKC (top). (B and C) Association between PKC and PIASy was tested by a mammalian two-hybrid assay. HeLa cells were transfected with plasmids containing Gal4-PKC wild type and VP16-PIASy (B) or truncated mutants of VP16-PIASy (C) as well as the Gal4-responsive luciferase reporter pG5-luc. After 24 h of transfection, cells were stimulated with 100 µM ONOO  or vehicle for 16 h, and luciferase activity was quantified. Luciferase activity was normalized with the Renilla luciferase (Luc.) activity (Woo et al., 2008) . Data are representative of three experiments using two or more different preparations of ECs (means ± SD; **, P < 0.01). (D) PIASy binding to PKC occurs via a domain consisting of aa 301-410 of PIASy. HeLa cells were transfected with each of the Flag-tagged PIASy fragments, and then pulldown assays were preformed using anti-Flag and IgG Sepharose beads in the presence of GST-fused recombinant PKC. Association of PIASy fragments with GST-PKC was assayed by Western blotting with anti-PKC. (bottom) PIASy fragment expression was detected by Western blotting with anti-Flag. (E) PIASy Fr3, but not Fr4, inhibited PKC-PIASy association. HUVECs were cotransfected with HA-tagged PKC wild type, Myc-tagged PIASy wild type, and Flag-tagged PIASy Fr3 or Fr4 for 24 h. Myc-PIASy wild type was immunoprecipitated with anti-Myc followed by immunoblotting with anti-HA (top). The expression of PKC, PIASy, and PIASy fragments was detected by Western blotting with specific antibodies. Data are representative of three independent experiments. (F) HUVECs were transfected with Flag-tagged PIASy Fr3 or Fr4 or control vectors for 24 h and then stimulated by d-flow for 3 h. p53 was immunoprecipitated using anti-p53, and d-flow-induced p53 SUMOylation was analyzed by immunoblotting with anti-SUMO2/3 (top). The expression of p53, SUMO, and PIASy fragments was detected by Western blotting with specific antibodies. Data are representative of three independent experiments. Molecular masses are given in kilodaltons. IB, immunoblot. IP, immunoprecipitation. WT, wild type. atherogenesis (Fig. 10 A) as described previously (Iiyama et al., 1999) and in the Materials and methods section. When the endothelium was double stained with anti-PKC or antiphospho-PKC together with anti-vascular endothelial (VE)-cadherin as an EC marker, we found that the expression of total PKC increased in the HP area (Fig. 10 B) , and especially phospho-PKC was significantly higher in the HP area compared with the LP area (Fig. 10 C) . Quantification of these data obtained from five mice supports this conclusion (Fig. 10, B and C, bar graph). These results confirm our in vitro results that show d-flow-dependent activation of PKC (Fig. 1) .
Next, aortas were immunostained with anti-p53 and then with TO-PRO3 for nucleus staining, and confocal microscopy was used to acquire a z series of fluorescence images. No significant fluorescent signal was observed in aorta samples treated with nonimmune rabbit IgG (not depicted) or with antigen-preabsorbed anti-p53 (Fig. S5 A) . In LP areas, p53 was localized mainly in the nucleus (Fig. 10, D and F) . In contrast, in HP areas, significant levels of anti-p53 staining were detected outside the nucleus, as previously reported (Zhong et al., 1993; Ghosh et al., 2004) . D-flow stimulation caused significant nuclear export of p53 and colocalization with Bcl-2. These data support d-flow-induced association of PKC-PIASy and p53-Bcl-2 in ECs.
En face immunohistochemistry of PKC, p53, nitrotyrosine, and apoptosis in mouse aorta
PKC activation in the ECs of the lesser curvature of the aortic arch in porcine aorta was recently reported (Magid and Davies, 2005) . Because activation of this kinase is proatherogenic, we investigated the expression of PKC, phosphorylated PKC, a nitrotyrosine-containing protein, p53, and apoptotic ECs using en face aorta preparations and confocal microscopy. Aortas from male wild-type C57BL/6 mice (6-8 wk old) fed with normal chow were isolated after perfusion fixation and en face preparations were made. We focused on areas designated as high probability (HP) regions (lesser curvature of aortic arch) and low probability (LP) regions (greater curvature of aortic arch) for apoptosis, especially under low stress conditions (Tian et al., 2000; Garner and Raj, 2008) . Indeed, our current study has revealed the antiapoptotic localization of p53 in ECs in the LP area exposed to steady laminar stress, which we consider to be a low stress condition. In contrast, ECs exposed to d-flow and ONOO  had increased cytoplasmic p53 localization (i.e., nuclear export of p53), which enhanced EC apoptosis via increased p53-Bcl-2 binding.
Little information is available regarding the pathological significance of p53 subcellular localization, especially in ECs. Our study suggests that PKC activation by d-flow and ONOO  and subsequent p53 nuclear export promote EC apoptosis. This notion is consistent with an earlier study showing that human cytomegalovirus infection of ECs induces p53 accumulation in the cytoplasm and apoptosis via a p53-dependent pathway (Shen et al., 2004) . Together, these results strongly suggest the involvement of cytoplasmic p53 in EC apoptosis (Utama et al., 2006) . Our en face confocal data are consistent with this idea because increased cytoplasmic anti-p53 staining and increased TUNEL and annexin V stainings are found in ECs located in the area exposed to d-flow (i.e., HP area).
In our in vitro study, we found the importance of ONOO  on d-flow-mediated PKC activation, p53 SUMOylation, and EC apoptosis using ebselen, L-NAME, and Mn-TBAP (Fig. 5 ).
In addition, we found that nitrotyrosine staining was significantly increased in d-flow (HP) areas in vivo (Fig. S5, B-D) , where PKC activation, nuclear exports of p53, and EC apoptosis were increased. We used 10-100 µM ONOO  as the final concentration, which is in agreement with the concentration of ONOO  used in previous studies by other investigators (Alvarez et al., 2004; Levrand et al., 2005; Szabó et al., 2007) . Because ONOO  is a transient intermediate in free radical chemistry and is highly reactive, it is difficult to measure actual concentrations of ONOO  in vivo. However, 10-100 µM ONOO  are thought to be physiological because it has been suggested that the rates of ONOO  production in vivo in specific compartments have been estimated to be as high as 50-100 µM/min (Alvarez et al., 2004; Levrand et al., 2005; Szabó et al., 2007) . In addition, it has also been estimated that the rate of ONOO  generation may reach up to 1 mM/min in an inflamed organ (lung) in vivo (Ischiropoulos et al., 1992) . ONOO  has several possible ways to activate PKC. One of the major effects of ONOO  is protein tyrosine nitration, which can regulate a variety of kinases (Liaudet et al., 2009) . First, ONOO  can activate various receptor tyrosine kinases (Klotz et al., 2000; Zhang et al., 2000) . Second, ONOO  can activate Src by displacing Tyr527 from its binding site to the SH2 domain (Roskoski, 2005) . Finally, ONOO  can inhibit phosphatases via oxidation of cysteine-bound thiols (Takakura et al., 1999) . Although the direct effect of ONOO  on PKC remains unclear, these molecules may be involved in signaling events upstream of PKC. Therefore, we hypothesize that activation of a variety of kinases may be involved in ONOO  -mediated PKC activation. Further studies are necessary to determine the major signaling events.
In addition to regulating cell physiology through kinase activities, active kinases can also regulate cell physiology by altering their interaction with other molecules (Akaike et al., 2004; Boggon and Eck, 2004) . PKC contains the pseudosubstrate although anti-p53 staining was still associated with the nucleus. This cytoplasmic staining was localized primarily to the area underneath the nucleus (Fig. 10, E and F) . These results appear to suggest that d-flow causes p53, which is present mainly in the nucleus in ECs exposed to s-flow (i.e., LP area), to translocate into the cytoplasm especially to the area directly below the nucleus.
We also examined whether ECs in the HP area underwent more apoptosis than ECs in the LP area. Aortas of 7-wk-old C57BL/6 mice were immunostained first for VE-cadherin (Fig. S4 A, red) followed by the TUNEL staining (Fig. S4 A) or were coimmunostained for annexin V (Fig. S4 B, red) and VE-cadherin (Fig. S4 B, green) . Although, in the LP area, TUNELand annexin V-positive cells were rarely detected, such cells were frequently detected in the HP area (Fig. S4, A and B) . Next, we studied the role of p53 in EC apoptosis in the 7-wk-old p53-deficient C57BL/6 mice (p53 / ; Fig. 10, G and H) . p53 was absent in lung ECs isolated from p53 / mice (Fig. 10 H,  right) . Interestingly, annexin V-positive cells in the HP area were significantly decreased in the p53 / mice (Fig. 10, G and H) , supporting the critical role of p53 on d-flow-mediated apoptosis in vivo. Because we found the critical role of ONOO  in d-flowmediated PKC activation, p53 SUMOylation, and apoptosis, we investigated the expression of nitrotyrosine-containing proteins by double staining aortas with anti-VE-cadherin and antinitrotyrosine (Fig. S5, B-D) . Antinitrotyrosine staining was significantly higher in HP areas than in LP areas. Our data collectively suggest that d-flow induces ONOO  production, PKC activation, and nuclear export of p53, which increases EC apoptosis, and may prime ECs in the d-flow (HP) area to become susceptible to atherogenesis under the influence of various systemic risk factors.
Discussion
Several atheroprotective signals activated by s-flow have been identified, but atheroprone signaling activated by d-flow is not well understood. The main finding of this study is that d-flowmediated ONOO  production activates PKC and induces p53 SUMOylation, p53 nuclear export, p53-Bcl-2 binding, and subsequent apoptosis. p53 appears to have both yin and yang effects on blood vessel physiology. Recent studies show its protective effect against cell death (Tian et al., 2000; Garner and Raj, 2008) . Because p53 positively regulates the expression of p21, an antiapoptotic protein (Garner and Raj, 2008) , p53 may exert its antiapoptotic effect by increasing p21 expression. Previously, Lin et al. (2000) have reported that laminar shear stress increased p53 expression and JNK-mediated p53 phosphorylation, which leads to endothelial growth arrest via increasing GADD45 and p21 cip1 expression. Therefore, it is important to emphasize here that p53 can induce growth arrest by inhibiting apoptosis via regulating p21. The interplay between cell cycle arrest and apoptosis is possibly critical in maintaining endothelial function because p53 may be able to reduce cells with DNA damages from apoptosis by preventing entry into the S phase (Garner and Raj, 2008) . However, it remains unclear how p53 determines which of these two activities, pro-or antiapoptotic, to implement. Of note, most of the p53 antiapoptotic effects have been explained by its nuclear localization, as nuclear p53 protects cells from Fixed aortas of wild-type mice were cut longitudinally, and the arch region was further cut into two halves. Areas of d-flow (HP area; lesser curvature) are outlined in red, and neighboring areas of s-flow (LP area) are lined in blue. a, artery. (B and C) En face preparations were double stained with anti-VE-cadherin (VE-cad; used as an EC marker) and an anti-total PKC antibody (B) or phospho-PKC T560 antibody (C). X-y axis images were collected at 0.5-µm increments so that a z stack of 4-µm thickness from the luminal surface was obtained. From each image background, fluorescence intensity was subtracted, and the pixel number of the stained region per unit area of the endothelium in HP and LP area within the aortic arch was determined (n = 3). Areas of d-flow (HP areas; lesser curvature) show both increased total and phospho-PKC expression compared with the neighboring areas of s-flow (LP area). Bars, 20 µm. Bar graphs show quantification of total (B) and phospho (C)-PKC in HP and LP areas. Data are shown as means ± SEM; *, P < 0.05. (D and E) Increased cytoplasmic p53 localization in HP area ECs. Aortic arches were immunostained for endothelial p53 (green). Nuclei were stained using TO-PRO3 (red). From initial stacked x-y axis images (top), a narrow rectangular area crossing an EC was selected for x-y-z scanning at 0.1-µm increments. Images below the clipped images show rectangular z-axis images. Two representative sets of images (i and ii) are shown for LP (D) and HP (E) areas. Bars, 10 µm. (F) Quantification of nuclear p53. The pixel number of antibodies for p-PKC were purchased from Cell Signaling Technology (Thr 410; 9378) and Abcam (Thr 560; ab62372). The rabbit and mouse anti-SUMO2/3 were purchased from Abgent (AP1224a) and MBL International (M114-3), respectively. Anti-PIASy was purchased from Abcam (ab58416) and Sigma-Aldrich (P0104). Rat anti-VE-cadherin was purchased from BD (555289). ON-TARGETplus SMARTpool for human PKC siRNA was purchased from Thermo Fisher Scientific (L-003526-00), and a nonspecific control siRNA obtained from Invitrogen (12935-122) was used as a negative control. The Ad-DN-PKC was purchased from Cell Biolabs. The Ad-DN-PKC was generated by mutating the ATP binding site (K281M) from human PKC (NCBI Protein database accession no. NP_002735; Diaz-Meco et al., 1993) . GST-fused active recombinant human PKC was purchased from Stressgen (PPK-468). Peroxynitrite was purchased form EMD. Alexa Fluor 488-conjugated mouse antinitrotyrosine was purchased from Millipore (16-226).
Cell culture and transfection of the PKC and PIASy siRNAs HUVECs were obtained from collagenase-digested umbilical cord veins (Takahashi and Berk, 1996) and collected in M200 medium supplemented with low serum growth supplement (Cascade Biological) and 5% fetal calf serum (Invitrogen). HUVECs were cultured on 0.2% gelatin-precoated dishes. For transient expression experiments, transfection of the PKC SMARTpool siRNA or PIASy siRNA was performed using Lipofectamine 2000 (Invitrogen) following protocols provided by the manufacturer. The Stealth RNAi Negative Control Med GC (Invitrogen), which has no homology to the vertebrate transcriptome, was used as a negative control. The cells were harvested 48 h after siRNA transfection, and protein expressions were monitored by immunoblotting with antibodies against PKC, PIASy, or tubulin. The target and control sequences for PIASy siRNAs were 5-CAAGACAG-GUGGAGUUGAU-3 and 5-UACCGUCUCCACUUGAUCG-3.
Flow apparatus
To expose a large number of cells to flow, we used a cone and plate flow apparatus identical to the one used previously (Reinhart-King et al., 2008) . Confluent HUVECs cultured in 100-mm dishes were exposed to s-flow in a flow apparatus placed in a cell culture incubator with 5% CO 2 and at 37°C for long-term experiments (shear stress = 20 dyn/cm 2 ). To expose cells to d-flow, we used a cone with radial grooves. Shear stress induced by d-flow cannot be calculated, but we rotated the cone with 50 rpm that gives 5 dyn/cm 2 of laminar shear stress. We optimized and chose this speed because ECs maintained nonelongated cell shapes with this speed.
Analysis of apoptosis
In accordance with recently published guidelines, apoptosis was quantified by multiple methodologically unrelated criteria (Galluzzi et al., 2009 ). To induce apoptosis, HUVECs were treated with 100 µM ONOO  or d-flow. Phosphatidylserine externalization was quantified by staining cells with annexin V-Alexa Fluor 568 (Roche), and late-stage apoptosis was quantified morphologically by counting cells showing evidence of positive staining for TUNEL (Ding et al., 2000) . TUNEL analyses were performed according to the manufacturer's instructions, and the cells were counterstained with DAPI (Sigma-Aldrich) to identify nuclei. For each experiment in vitro, a total of 150-200 cells were counted from randomly selected fields of view, and TUNEL-positive cells were expressed as a percentage of total cells counted. Samples were examined using a 40× lens under a fluorescence microscope (BX51; Olympus) capable of imaging two distinct channels without adjustment of the microscope stage position. 10 random fields per sample were examined. Apoptosis was also quantified by Western blot assessment of the cleavage of the caspase 3 using the cleaved caspase 3 antibody. All measurements were performed blinded, and at least three independent experiments were performed.
Mammalian two-hybrid analysis and transfection of cells Cells were plated in 12-well plates at 5 × 10 4 cells/well. The mammalian twohybrid assay was performed as described previously (Woo et al., 2006) . autoinhibitory sequence (aa 116-122) , and the release of the kinase domain (aa 268-587) from this autoinhibitory domain leads to PKC activation (Newton, 2001; Smith et al., 2003) . In this study, we were unable to show PKC-mediated phosphorylation of PIASy in our in vitro kinase assay (Fig. S3 ), but we found that activation of PKC increased the PKC-PIASy interaction (Fig. 8) . Using a mammalian two-hybrid assay, we then determined the C-terminal kinase domain of PKC (aa 401-587) was a PIASy binding site (Fig. 8 C) . Of note, the deletion of the N-terminal autoinhibitory domain of PKC (aa 1-200) increased PKC-PIASy association, suggesting that this domain is a negative regulator not only of its kinase activity but also its binding ability with PIASy. Therefore, releasing the PKC N-terminal inhibitory effect (i.e., activation of PKC) is critical for both kinase activation and PKC-PIASy association, and the regulation of PIASy activity most likely depends on PKC-mediated increase in PKC-PIASy association but not phosphorylation. We also found that PKC binds to the RING domain of PIASy, which contains its catalytic site and may alter the structure and enzymatic activity of PIASy. Our findings suggest that d-flow-mediated PKC-PIASy association is critical for p53 SUMOylation to induce the endothelial p53 nuclear export and apoptosis.
Materials and methods
Animals
C57BL/6 and p53
/ mice with a C57BL/6 background (P53N4-M) were purchased from Taconic. All mice were maintained under pathogen-free conditions at the Aab Cardiovascular Research Institute at the University of Rochester. All animal procedures were performed with the approval of the University Committee on Animal Resources at the University of Rochester.
Plasmid and adenovirus vector construction
The plasmid encoding human HA-SUMO3 was a gift from R.T. Hay (University of Manchester, Manchester, England, UK; Tatham et al., 2001) . The pcDNA3-Myc-PIASy and pcDNA-HA-PKC constructs were gifts from M. Takahashi (Nagoya University, Chikusa-ku, Nagoya, Japan; Matsuura et al., 2005) and J.-W. Soh (Columbia University, New York, NY; Soh et al., 1999) , respectively. The p53-luciferase (p53-luc) reporter (Addgene plasmid 16442; B. Vogelstein, Johns Hopkins University School of Medicine, Baltimore, MD; el-Deiry et al., 1993) and pcDNA-Flag-p53 (Addgene plasmid 10838; T. Roberts, Harvard Medical School, Boston, MA; el-Deiry et al., 1993; Gjoerup et al., 2001) were obtained from the nonprofit Addgene plasmid repository. The Gal4 wild-type and truncated forms of PKC were created by inserting a KpnI-XbaI fragment generated by PCR into the pBIND vector (Promega). V16-PIASy was created by inserting human PIASy isolated from pcDNA3-PIASy into BamH1 and EcoRV1 sites of the pACT vector. Truncated forms of PIASy were constructed by inserting fragments EcoRIXhoI or BamHI-XhoI generated by PCR into the pGEX-KG or pCMV-Taq2B vector, respectively. All constructs were verified by DNA sequencing. 
En face immunohistochemistry
The s-flow and d-flow areas within the aorta were identified based on the published and generally accepted anatomical locations where such flow patterns are known to occur (Iiyama et al., 1999; Hajra et al., 2000; Jongstra-Bilen et al., 2006) . For example, a typical s-flow area is located in the greater curvature area and is marked as an LP region for lesion formation (Hajra et al., 2000) , which is also known as a high wall shear stress area. A d-flow area is the lesser curvature area (HP region; Iiyama et al., 1999; Hajra et al., 2000; Jongstra-Bilen et al., 2006) , which is also indicated as a low wall shear stress area. In the Fig. 10 legend, we indicated these two areas in the aortic arch. EC shape outlined by anti-VE-cadherin staining was also used to identify s-flow areas (elongated cell shape) and d-flow areas (irregular cell shape). It has been reported that PECAM-1 (CD31) staining, another marker of ECs, was localized to endothelial junctions in the HP region, whereas in the LP region, it is more diffuse. Therefore, the PECAM-1 staining at EC borders was much stronger in the HP region than in the LP region (Hajra et al., 2000) . We found the similar tendency of VE-cadherin staining in the mouse aorta. Because these data were very consistent in every mouse, we do not think that this is caused by the damage that specifically occurred in the LP region. C57BL/6 wild-type mice (Taconic) were fed standard chow. Animals of 6-8 wk of age were euthanized by CO 2 inhalation. The arterial tree was perfused via the left ventricle with saline containing 40 USPU/ml heparin followed by 4% paraformaldehyde in PBS for 10 min. After adipose tissues were removed, aortas were cut open longitudinally and permeabilized with PBS containing 0.1% Triton X-100 and blocked by TBS containing 10% goat serum and 2.5% Tween 20 for 30 min. Aortas were incubated with 10 µg/ml rabbit anti-p53 (FL-393; Santa Cruz Biotechnology, Inc.; rabbit IgG was used as a control) and 7 µg/ml rat anti-VE-cadherin (an EC marker; BD) in the blocking solution overnight. Specificity of anti-p53 staining was tested by staining with anti-p53 preabsorbed with recombinant p53 (Santa Cruz Biotechnology, Inc.) as shown in Fig. S4 . After a PBS rinse, anti-rabbit IgG and anti-rat IgG (1:1,000 dilution; Alexa Fluor 546 and 488, respectively; Invitrogen) were applied for 1 h at room temperature. Nuclei were stained using TO-PRO3 (Invitrogen). For the detection of apoptosis, we used two different methods. To perform an in situ TUNEL assay, aortas immunostained with anti-VE-cadherin (with Alexa Fluor 546 anti-rabbit IgG) were incubated in the TUNEL reaction mixture (Roche) for 1 h at 37°C according to the manufacturer's instructions (mixture without the enzyme TdT as a control). For annexin V labeling, we injected annexin V-Alexa Fluor 568 into aortas via the left ventricle after perfusion with saline containing 40 USPU/ml heparin followed by 4% paraformaldehyde in PBS for 10 min. Then, these aortas were immunostained with anti-VE-cadherin as described in the previous paragraph. Images were acquired using a confocal laserscanning microscope (Fluoview 300; Olympus) equipped with krypton/ argon/HeNe laser lines and 20× 0.70 NA, 40× 1.0 NA, and 60× 1.4 NA objectives. For quantification of phospho-and total PKC expression level, 10-15 optical sections were collected at 0.3-0.5-µm increments so that z stacks of 4-µm-thick cell blocks from the luminal surface were obtained. Images were collected using the same confocal settings. For quantification of EC apoptosis, aortas of 7-wk-old wild-type mice (n = 7 each) were prepared. Images were acquired as described in the previous paragraph. To analyze p53 subcellular localization, we took z-stack clip images of 50 optical sections collected at 0.1-µm increments from the luminal surface. We radially extended the edge of the nucleus by the length of the nuclear radius at each point along the edge of the nucleus and delineated an area for each cell. We defined the signal level in this area as total because practically all anti-p53 staining signals (>80-90%) were included in this area. Staining signal levels in the cytoplasm and the nucleus were determined. Confocal images were obtained from s-flow and d-flow areas as shown in Fig. 10 .
Statistical analysis
Data are reported as means ± SD. Statistical analysis was performed with the Prism program version 2.00 (GraphPad Software). Differences were analyzed with a one-way or a two-way repeated-measure analysis of variance as appropriate followed by Dunnett's correction for multiple comparisons. P < 0.05 is indicated by an asterisk, and P < 0.01 is indicated by a double asterisk.
Online supplemental material Fig. S1 shows that ONOO  increases p53 SUMOylation and p53-Bcl-2 binding. Fig. S2 shows d-flow-induced p53 nuclear export analyzed by immunostaining. Fig. S3 shows whether PKC phosphorylates PIASy in vitro by in vitro kinase assay. Fig. S4 shows apoptosis in d-flow and s-flow area of the mouse aortic arch endothelia analyzed by TUNEL and annexin V staining.
In brief, cells were transfected in Opti-MEM (Invitrogen) with Lipofectamine mixture containing the pG5-luc vector and various pBIND and pACT plasmids (Promega) for 4 h. Cells were washed, and fresh DME supplemented with 10% fetal bovine serum was added. The pBIND vector contains the yeast GAL4-DNA-binding domain upstream of a multiple cloning region, and the pACT vector contains the herpes simplex virus VP16 activation domain upstream of a multiple cloning region. Various PKC mutants and PIASy were cloned into the pBIND and pACT vector, respectively. Because pBIND also contains the Renilla luciferase gene, the expression and transfection efficiencies were normalized with the Renilla luciferase activity. Cells were collected 36 h after transfection unless indicated otherwise, and the luciferase activity was assayed with the Dual-Luciferase kit (Promega) using a luminometer (TD-20/20; Turner Designs). Transfections were performed in triplicate, and each experiment was repeated at least three times.
GST pull-down assay HeLa cells (10 6 cells) were plated in 100-mm dishes and transfected in Opti-MEM with Lipofectamine mixture containing the Flag-tagged PIASytruncated mutants for 4 h. Cells were washed and cultured for 24 h in fresh complete growth medium. Cell lysates were made by incubating cells in 0.5 ml radioimmunoprecipitation assay lysis buffer for 30 min at 4°C. After centrifugation for 20 min at 12,000 rpm, the whole-cell lysates were incubated with 100 ng of recombinant GST-fused PKC, anti-FLAG, and IgG Sepharose beads with constant mixing for 2-5 h at 4°C. The beads were then washed three times with lysis buffer, resuspended in SDS-PAGE sample buffer, and boiled for 8 min. Samples were separated on a 15% SDS-PAGE and analyzed by Western blotting using anti-PKC.
Immunohistochemistry and confocal microscopy
To determine whether the p53 localization is regulated by PKC activation, HUVECs grown in 6-well plates were transduced with Ad-LacZ or Ad-DN-PKC for 24 h. After treatment with 100 µM ONOO  for 4 h, the cells were quickly washed two times with cold PBS, fixed with 4% paraformaldehyde in PBS for 15 min, and then permeabilized with 0.2% Triton X-100 in PBS for 10 min. Cells were incubated with blocking buffer (5% goat serum and 0.1% NP-40 in PBS) for 60 min to block nonspecific binding and incubated with anti-p53 (1:200 dilution in 2% goat serum and 0.1% NP-40 in PBS) overnight at 4°C. The cells were washed three times with PBS and incubated with Alexa Fluor 546-labeled anti-rabbit IgG or Alexa Fluor 488-labeled anti-rabbit IgG 1 (1:2,000 dilution; Invitrogen) for 1 h at room temperature. The cells were counterstained with DAPI to identify nuclei. All of the images were collected using an epifluorescence microscope (BX51) equipped with a charge-coupled device camera (Spot; Diagnostic Instruments, Inc.) and an Acroplan water 60× W lens.
To determine the colocalization of p53 with Bcl-2 or PKC with PIASy, HUVECs were stimulated with d-flow for 3 h. After fixation, permeabilization, and 10% goat serum in PBS with 0.1% NP-40 for 1 h, the cells were incubated with mouse anti-p53 and rabbit anti-Bcl-2 or mouse anti-PKC and rabbit anti-PIASy (1:200) antibodies in 2% goat serum with PBS overnight at 4°C. The cells were washed three times with PBS and incubated with Alexa Fluor 546-labeled anti-mouse IgG and Alexa Fluor 488-labeled anti-rabbit IgG 1 (1:2,000 dilution) for 1 h at room temperature. The samples were analyzed using a laser-scanning confocal microscope (FV1000; Olympus) equipped with a Plapon 60× 1.42 NA oil lens objective. Quantification of the overlay image was performed using the Photoshop (CS; Adobe) program.
Immunoprecipitation (SUMO assay) and Western blot analysis Cells were collected in PBS containing 10 mM N-ethylmaleimide, and cell extracts were prepared in modified radioimmunoprecipitation assay buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% SDS, 1 mM dithiothreitol, 1:200-diluted protease inhibitor cocktail [SigmaAldrich], 1 mM PMSF, 10 mM N-ethylmaleimide, and 0.1 mM iodoacetamide). Immunoprecipitation with a mouse monoclonal anti-Flag, HA, or p53 was performed as described previously (Woo et al., 2006) . Bound proteins were released in 2× SDS sample buffer, resolved by SDS-PAGE, transferred onto an enhanced chemiluminescence nitrocellulose membrane (Hybond), and visualized by using the enhanced chemiluminescence detection reagents (GE Healthcare) according to the manufacturer's instructions. p53 SUMOylation was detected by immunoprecipitation with anti-p53 followed by Western blotting with anti-SUMO2/3. Results were normalized to the lowest phosphorylation level within each set of experiments, and statistical significance was determined by comparing the mean level of the control group to each of the experimental data points.
